Logo image of CTRN

CITI TRENDS INC (CTRN) Stock Fundamental Analysis

NASDAQ:CTRN - Nasdaq - US17306X1028 - Common Stock - Currency: USD

32.72  +0.51 (+1.58%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CTRN. CTRN was compared to 124 industry peers in the Specialty Retail industry. While CTRN seems to be doing ok healthwise, there are quite some concerns on its profitability. CTRN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CTRN had negative earnings in the past year.
CTRN had a positive operating cash flow in the past year.
In multiple years CTRN reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: CTRN reported negative operating cash flow in multiple years.
CTRN Yearly Net Income VS EBIT VS OCF VS FCFCTRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

The Return On Assets of CTRN (-8.89%) is worse than 72.58% of its industry peers.
CTRN has a worse Return On Equity (-35.81%) than 64.52% of its industry peers.
Industry RankSector Rank
ROA -8.89%
ROE -35.81%
ROIC N/A
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-3.45%
ROE(5y)11.58%
ROIC(3y)N/A
ROIC(5y)N/A
CTRN Yearly ROA, ROE, ROICCTRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

CTRN has a Gross Margin (37.71%) which is comparable to the rest of the industry.
CTRN's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for CTRN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.05%
GM growth 5Y-0.3%
CTRN Yearly Profit, Operating, Gross MarginsCTRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

More info and screens

6

2. Health

2.1 Basic Checks

CTRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CTRN remains at a similar level compared to 1 year ago.
CTRN has less shares outstanding than it did 5 years ago.
CTRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CTRN Yearly Shares OutstandingCTRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
CTRN Yearly Total Debt VS Total AssetsCTRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

CTRN has an Altman-Z score of 2.96. This is not the best score and indicates that CTRN is in the grey zone with still only limited risk for bankruptcy at the moment.
CTRN has a better Altman-Z score (2.96) than 64.52% of its industry peers.
CTRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.96
ROIC/WACCN/A
WACC9.44%
CTRN Yearly LT Debt VS Equity VS FCFCTRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

CTRN has a Current Ratio of 1.12. This is a normal value and indicates that CTRN is financially healthy and should not expect problems in meeting its short term obligations.
CTRN's Current ratio of 1.12 is on the low side compared to the rest of the industry. CTRN is outperformed by 66.13% of its industry peers.
A Quick Ratio of 0.39 indicates that CTRN may have some problems paying its short term obligations.
CTRN has a Quick ratio of 0.39. This is comparable to the rest of the industry: CTRN outperforms 41.94% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.39
CTRN Yearly Current Assets VS Current LiabilitesCTRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

3

3. Growth

3.1 Past

CTRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -330.53%.
Looking at the last year, CTRN shows a small growth in Revenue. The Revenue has grown by 1.85% in the last year.
The Revenue has been decreasing by -0.75% on average over the past years.
EPS 1Y (TTM)-330.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%153.13%
Revenue 1Y (TTM)1.85%
Revenue growth 3Y-8.76%
Revenue growth 5Y-0.75%
Sales Q2Q%8.29%

3.2 Future

The Earnings Per Share is expected to grow by 24.22% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 6.03% on average over the next years.
EPS Next Y73.05%
EPS Next 2Y47.36%
EPS Next 3Y35.42%
EPS Next 5Y24.22%
Revenue Next Year4.65%
Revenue Next 2Y4.63%
Revenue Next 3Y4.99%
Revenue Next 5Y6.03%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CTRN Yearly Revenue VS EstimatesCTRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
CTRN Yearly EPS VS EstimatesCTRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4 6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

CTRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
CTRN is valuated quite expensively with a Price/Forward Earnings ratio of 41.66.
CTRN's Price/Forward Earnings is on the same level as the industry average.
CTRN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 35.24, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 41.66
CTRN Price Earnings VS Forward Price EarningsCTRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CTRN Per share dataCTRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

CTRN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CTRN's earnings are expected to grow with 35.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.36%
EPS Next 3Y35.42%

More info and screens

0

5. Dividend

5.1 Amount

CTRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CITI TRENDS INC

NASDAQ:CTRN (8/19/2025, 10:59:38 AM)

32.72

+0.51 (+1.58%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)06-03 2025-06-03/bmo
Earnings (Next)08-25 2025-08-25/bmo
Inst Owners94.4%
Inst Owner Change-42.87%
Ins Owners10.86%
Ins Owner Change1.02%
Market Cap271.25M
Analysts82.5
Price Target39.27 (20.02%)
Short Float %5.89%
Short Ratio6
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-376.65%
Min EPS beat(2)-938.78%
Max EPS beat(2)185.47%
EPS beat(4)1
Avg EPS beat(4)-258.15%
Min EPS beat(4)-938.78%
Max EPS beat(4)185.47%
EPS beat(8)2
Avg EPS beat(8)-156.03%
EPS beat(12)4
Avg EPS beat(12)-105.71%
EPS beat(16)8
Avg EPS beat(16)-56.54%
Revenue beat(2)1
Avg Revenue beat(2)-0.59%
Min Revenue beat(2)-2.13%
Max Revenue beat(2)0.95%
Revenue beat(4)1
Avg Revenue beat(4)-1.8%
Min Revenue beat(4)-3.37%
Max Revenue beat(4)0.95%
Revenue beat(8)2
Avg Revenue beat(8)-1.87%
Revenue beat(12)3
Avg Revenue beat(12)-2.19%
Revenue beat(16)6
Avg Revenue beat(16)-1.66%
PT rev (1m)0%
PT rev (3m)26.23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.33%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.59%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 41.66
P/S 0.35
P/FCF N/A
P/OCF 56.56
P/B 2.5
P/tB 2.5
EV/EBITDA N/A
EPS(TTM)-4.09
EYN/A
EPS(NY)0.79
Fwd EY2.4%
FCF(TTM)-0.7
FCFYN/A
OCF(TTM)0.58
OCFY1.77%
SpS92.7
BVpS13.1
TBVpS13.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.89%
ROE -35.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.71%
FCFM N/A
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-3.45%
ROE(5y)11.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.05%
GM growth 5Y-0.3%
F-Score4
Asset Turnover1.76
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 57.73%
Cap/Sales 1.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.39
Altman-Z 2.96
F-Score4
WACC9.44%
ROIC/WACCN/A
Cap/Depr(3y)80.1%
Cap/Depr(5y)94.79%
Cap/Sales(3y)2.05%
Cap/Sales(5y)2.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-330.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%153.13%
EPS Next Y73.05%
EPS Next 2Y47.36%
EPS Next 3Y35.42%
EPS Next 5Y24.22%
Revenue 1Y (TTM)1.85%
Revenue growth 3Y-8.76%
Revenue growth 5Y-0.75%
Sales Q2Q%8.29%
Revenue Next Year4.65%
Revenue Next 2Y4.63%
Revenue Next 3Y4.99%
Revenue Next 5Y6.03%
EBIT growth 1Y-85.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year121.37%
EBIT Next 3Y45.76%
EBIT Next 5Y30.74%
FCF growth 1Y-57.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-58.66%
OCF growth 3YN/A
OCF growth 5YN/A